Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8366) 8366
Publication (254) 254
Newsletter (123) 123
Book Review (52) 52
Book Chapter (12) 12
Dissertation (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4525) 4525
male (4292) 4292
imipramine - pharmacology (3719) 3719
imipramine (3519) 3519
humans (3068) 3068
rats (2988) 2988
pharmacology & pharmacy (2558) 2558
female (2043) 2043
psychiatry (1407) 1407
adult (1292) 1292
neurosciences (1235) 1235
antidepressive agents - pharmacology (1141) 1141
mice (1079) 1079
depression (923) 923
middle aged (914) 914
antidepressants (902) 902
imipramine - therapeutic use (896) 896
dose-response relationship, drug (793) 793
index medicus (775) 775
time factors (709) 709
in vitro techniques (700) 700
antidepressive agents, tricyclic - pharmacology (694) 694
imipramine - metabolism (669) 669
depressive disorder - drug therapy (634) 634
rats, inbred strains (623) 623
brain - metabolism (617) 617
serotonin - metabolism (616) 616
rats, wistar (572) 572
clinical neurology (570) 570
behavior, animal - drug effects (550) 550
serotonin (539) 539
chlorpromazine - pharmacology (534) 534
kinetics (534) 534
fluoxetine (520) 520
depression - drug therapy (513) 513
motor activity - drug effects (506) 506
desipramine - pharmacology (504) 504
brain (499) 499
antidepressive agents - therapeutic use (486) 486
desipramine (481) 481
aged (463) 463
amitriptyline - pharmacology (463) 463
brain - drug effects (445) 445
double-blind method (441) 441
drug interactions (432) 432
imipramine - administration & dosage (429) 429
major depression (404) 404
rats, sprague-dawley (397) 397
blood platelets - metabolism (396) 396
antidepressant (382) 382
adolescent (370) 370
amitriptyline (366) 366
tricyclic antidepressants (347) 347
psychiatric status rating scales (346) 346
disease models, animal (343) 343
drugs (323) 323
depression, mental (322) 322
imipramine - blood (320) 320
rat (319) 319
pharmacology (318) 318
norepinephrine - metabolism (316) 316
research (308) 308
depressive disorder - psychology (305) 305
reserpine - pharmacology (284) 284
fluoxetine - pharmacology (279) 279
double-blind (277) 277
rabbits (277) 277
imipramine - adverse effects (275) 275
drug synergism (271) 271
biochemistry & molecular biology (269) 269
anxiety (265) 265
placebo (264) 264
antidepressive agents, tricyclic - therapeutic use (263) 263
clinical trials as topic (262) 262
treatment outcome (246) 246
serotonin uptake inhibitors - pharmacology (241) 241
swimming (240) 240
hippocampus - drug effects (238) 238
paroxetine (236) 236
cats (231) 231
analysis (229) 229
forced swimming test (227) 227
cerebral cortex - metabolism (226) 226
rat-brain (222) 222
toxicology (212) 212
blood pressure - drug effects (211) 211
imipramine - pharmacokinetics (210) 210
tritium (210) 210
receptors (204) 204
dogs (203) 203
norepinephrine - pharmacology (197) 197
stress (194) 194
behavioral sciences (192) 192
dopamine (190) 190
analysis of variance (189) 189
hippocampus (186) 186
amphetamine - pharmacology (184) 184
electroencephalography (184) 184
hippocampus - metabolism (183) 183
metabolism (183) 183
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7794) 7794
Russian (192) 192
German (161) 161
French (115) 115
Japanese (100) 100
Italian (41) 41
Spanish (23) 23
Polish (19) 19
Ukrainian (12) 12
Romanian (10) 10
Czech (7) 7
Chinese (6) 6
Bulgarian (5) 5
Dutch (5) 5
Danish (3) 3
Norwegian (3) 3
Hungarian (2) 2
Portuguese (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers
by Fišar, Zdeněk and Hroudová, Jana and Raboch, Jiří
Neuroendocrinology Letters, ISSN 0172-780X, 2010, Volume 31, Issue 5, pp. 645 - 656
OBJECTIVE: Monoamine oxidase (MAO), the enzyme responsible for metabolism of monoamine neurotransmitters, has an important role in the brain development and... 
Mood stabilizers | Monoamine oxidase inhibitors | Antidepressive agents | RAT-LIVER | antidepressive agents | monoamine oxidase inhibitors | FRONTAL-CORTEX | REUPTAKE INHIBITORS | MAJOR DEPRESSION | HUMAN PLATELET | mood stabilizers | NEUROSCIENCES | TRICYCLIC ANTIDEPRESSANTS | MONO-AMINE OXIDASE | ENDOCRINOLOGY & METABOLISM | MAO INHIBITORS | REVERSIBLE INHIBITORS | PARKINSONS-DISEASE | Mitochondria - enzymology | Citalopram - pharmacology | Clorgyline - pharmacology | Monoamine Oxidase - drug effects | Cerebral Cortex - cytology | Valproic Acid - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Swine | Antidepressive Agents - pharmacology | Cyclohexanols - pharmacology | Moclobemide - pharmacology | Fluoxetine - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Affect - drug effects | Benzodiazepines - pharmacology | Antimanic Agents - pharmacology | Lithium - pharmacology | Morpholines - pharmacology | Thiazepines - pharmacology | Mitochondria - drug effects | Iproniazid - pharmacology | Venlafaxine Hydrochloride | Cocaine - pharmacology | Animals | Pargyline - pharmacology | Amitriptyline - pharmacology | Imipramine - pharmacology | In Vitro Techniques | Monoamine Oxidase - metabolism
Journal Article
Details down arrow
2. Full Text Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels
by Zimmermann, Nicole and Zschocke, Jürgen and Perisic, Tatjana and Yu, Shuang and Holsboer, Florian and Rein, Theo
Biochemical Journal, ISSN 0264-6021, 11/2012, Volume 448, Issue 1, pp. 93 - 102
The discovery of epigenetic processes as possible pivotal regulatory mechanisms in psychiatric diseases raised the question of how psychoactive drugs may... 
Antidepressant | Epigenetics | Histone methyltransferase | DNA methyltransferase 1 (DNMT1) | Astrocyte | Mood stabilizer | METHYLATION | INDUCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | antidepressant | FLUVOXAMINE | mood stabilizer | FLUOXETINE | epigenetics | P-GLYCOPROTEIN | histone methyltransferase | GDNF | PHARMACOKINETICS | DEMETHYLATION | IN-VIVO | astrocyte | BRAIN | Citalopram - pharmacology | Maleimides - pharmacology | Astrocytes - enzymology | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Cerebral Cortex - cytology | DNA (Cytosine-5-)-Methyltransferases - metabolism | Histone-Lysine N-Methyltransferase - antagonists & inhibitors | Neurons - physiology | Indoles - pharmacology | Antidepressive Agents - pharmacology | Cyclohexanols - pharmacology | Neurons - drug effects | Astrocytes - drug effects | Carbamazepine - pharmacology | Nerve Tissue Proteins - antagonists & inhibitors | Cells, Cultured - drug effects | Histone-Lysine N-Methyltransferase - pharmacology | DNA (Cytosine-5-)-Methyltransferase 1 | Enzyme Inhibitors - pharmacology | Glycolipids - pharmacology | Neural Stem Cells - drug effects | Cells, Cultured - physiology | Neural Stem Cells - physiology | Rats | Recombinant Proteins - pharmacology | Neural Stem Cells - enzymology | Rats, Sprague-Dawley | Cells, Cultured - enzymology | Protein Interaction Mapping | Nerve Tissue Proteins - metabolism | Venlafaxine Hydrochloride | Astrocytes - physiology | Animals | Cerebral Cortex - embryology | Histone-Lysine N-Methyltransferase - metabolism | Neurons - enzymology | Mice | Imipramine - pharmacology | Paroxetine - pharmacology | DNA Methylation - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
by Wesołowska, Anna and Tatarczyńska, Ewa and Nikiforuk, Agnieszka and Chojnacka-Wójcik, Ewa
European Journal of Pharmacology, ISSN 0014-2999, 01/2007, Volume 555, Issue 1, pp. 43 - 47
Using the forced swimming test in mice, we examined the effect of the following antidepressants: citalopram, imipramine, desipramine and moclobemide (which are... 
Imipramine | Desipramine | Forced swimming test in mice | 5-HT | receptor antagonist | Moclobemide | Citalopram | DEPRESSION | MODIFY | 5-HT7 receptor antagonist | imipramine | SB-269970 | RATS | forced swimming test in mice | FLUOXETINE | desipramine | SEROTONIN REUPTAKE INHIBITORS | NEURONS | PHARMACOLOGY & PHARMACY | AGENTS | moclobemide | BLOCKADE | citalopram | Monoamine Oxidase Inhibitors - pharmacology | Citalopram - pharmacology | Motor Activity - drug effects | Male | Serotonin Antagonists - pharmacology | Sulfonamides - pharmacology | Receptors, Serotonin - metabolism | Desipramine - pharmacology | Animals | Drug Interactions | Adrenergic Uptake Inhibitors - pharmacology | Antidepressive Agents - pharmacology | Mice | Swimming | Moclobemide - pharmacology | Imipramine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Phenols - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antidepressant-like action of the hydromethanolic flower extract of Tagetes erecta L. in mice and its possible mechanism of action
by Khulbe, Aarti and Pandey, Savita and Sah, Sangeeta
Indian Journal of Pharmacology, ISSN 0253-7613, 07/2013, Volume 45, Issue 4, pp. 386 - 390
Objective: Tagetes erecta, the marigold, has commercial and ethnomedicinal use; however, reports concerning its efficacy for the treatment of depression are... 
Antidepressant | nitric oxide pathway | sigma receptors | serotonergic pathway | Tagetes erecta | forced swim test | INVOLVEMENT | PHARMACOLOGY & PHARMACY | SEROTONIN | Plant Extracts - pharmacology | Motor Activity - drug effects | Nitric Oxide Synthase - antagonists & inhibitors | Male | Receptors, sigma - antagonists & inhibitors | Flowers | Sulfones - pharmacology | Sildenafil Citrate | Water - chemistry | Antidepressive Agents - pharmacology | Methanol - chemistry | Phosphodiesterase 5 Inhibitors - pharmacology | Progesterone - pharmacology | Fenclonine - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Fluoxetine - pharmacology | Purines - pharmacology | Pentazocine - pharmacology | Receptors, sigma - agonists | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Animals | Arginine - pharmacology | Adrenergic Uptake Inhibitors - pharmacology | Mice | Tagetes | Imipramine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Care and treatment | Marigolds | Chemical properties | Health aspects | Depression, Mental | Pharmacology | Mental depression | Antidepressants | Natural products
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures
by Seo, Mi Kyoung and Lee, Jung Goo and Lee, Chan Hong and Lee, Bong Ju and Cho, Hye Yeon and Kim, Young Hoon and Kim, Ji Eun and Seol, Wongi and Park, Sung Woo
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 222 - 233
The alteration of hippocampal plasticity has been proposed to play a critical role in both the pathophysiology and treatment of depression. In this study, the... 
Signaling | Dendritic outgrowth | Hippocampal plasticity | Synaptic proteins | Antidepressant drugs | SPINE FORMATION | RECEPTOR SUBUNITS | BDNF LEVELS | CA3 PYRAMIDAL NEURONS | STRESS-INDUCED CHANGES | MAJOR DEPRESSION | FLUOXETINE | NEUROSCIENCES | SYNAPTOPHYSIN | MESSENGER-RNA | PHARMACOLOGY & PHARMACY | RAT HIPPOCAMPUS | Dendrites - drug effects | Fluoxetine - pharmacology | Citalopram - pharmacology | Sertraline - pharmacology | Cells, Cultured | Rats | Antidepressive Agents, Second-Generation - pharmacology | Thiazepines - pharmacology | Hippocampus - drug effects | Nerve Tissue Proteins - drug effects | Rats, Sprague-Dawley | Animals | Cell Enlargement - drug effects | Antidepressive Agents, Tricyclic - pharmacology | Dendrites - physiology | Tranylcypromine - pharmacology | Neurons - physiology | Antidepressive Agents - pharmacology | Hippocampus - physiology | Imipramine - pharmacology | Neurons - drug effects | Paroxetine - pharmacology | Drugs | Proteins | Paroxetine | Imipramine | Medical colleges | Neurosciences | Fluoxetine | Neurons | Analysis | Depression, Mental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Plurality of anxiety and depression alteration mechanism by oleanolic acid
by Fajemiroye, James O and Galdino, Pablinny M and Florentino, Iziara F and Da Rocha, Fabio F and Ghedini, Paulo C and Polepally, Prabhakar R and Zjawiony, Jordan K and Costa, Elson A
Journal of Psychopharmacology, ISSN 0269-8811, 10/2014, Volume 28, Issue 10, pp. 923 - 934
Our study sought to evaluate the anxiolytic and antidepressant activities of oleanolic acid as well as the neural mechanisms involved. Animal models such as... 
metabolic enzymes | anxiolytic | neurotrophic factor | monoamine | antidepressant | Oleanolic acid | MONOAMINE-OXIDASE | TAIL SUSPENSION TEST | PSYCHIATRY | FORCED SWIMMING TEST | ELEVATED PLUS-MAZE | NEUROSCIENCES | CLINICAL NEUROLOGY | ANTIDEPRESSANT ACTIVITY | NEUROTROPHIC FACTORS | NITRIC-OXIDE PRODUCTION | ANIMAL-MODELS | PHARMACOLOGY & PHARMACY | GABA(A) RECEPTORS | MOUSE MACROPHAGES | Fenclonine - analogs & derivatives | Motor Activity - drug effects | Oleanolic Acid - pharmacology | Male | Hippocampus - drug effects | Diazepam - pharmacology | Brain - metabolism | Dose-Response Relationship, Drug | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | alpha-Methyltyrosine - pharmacology | Fenclonine - pharmacology | Pentylenetetrazole - pharmacology | Disease Models, Animal | Fluoxetine - pharmacology | Anti-Anxiety Agents - pharmacology | Piperazines - pharmacology | Oleanolic Acid - antagonists & inhibitors | Brain - drug effects | Hippocampus - metabolism | Animals | Mice | Pyridines - pharmacology | Imipramine - pharmacology | Monoamine Oxidase - metabolism | Psychotropic drugs | Pharmacology, Experimental | Terpenoids | Depression, Mental | Physiological aspects | Anxiety | Research | Drug therapy | Health aspects | Neurotrophic functions
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pharmacophore modeling for hERG channel facilitation
by Yamakawa, Yuko and Furutani, Kazuharu and Inanobe, Atsushi and Ohno, Yuko and Kurachi, Yoshihisa
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2012, Volume 418, Issue 1, pp. 161 - 166
â–º We constructed the pharmacophore model for hERG channel facilitation. â–º This model consists of one positively ionizable feature and three hydrophobic... 
Facilitation | Pharmacology | hERG channel | Pharmacophore model | HERG channel | INTERVAL PROLONGATION | K+ CURRENT | BIOCHEMISTRY & MOLECULAR BIOLOGY | BLOCK | CARDIAC-ARRHYTHMIA | PREDICTION | RECTIFIER | BIOPHYSICS | TORSADE-DE-POINTES | DRUGS | LONG-QT-SYNDROME | POTASSIUM CHANNEL | Nortriptyline - chemistry | Metoprolol - pharmacology | Humans | Sotalol - chemistry | Imipramine - chemistry | ERG1 Potassium Channel | Nortriptyline - pharmacology | Propranolol - pharmacology | Chlorpheniramine - chemistry | Ether-A-Go-Go Potassium Channels - physiology | Metoprolol - chemistry | Haloperidol - pharmacology | Potassium Channel Blockers - pharmacology | Quantitative Structure-Activity Relationship | Atenolol - pharmacology | Terfenadine - pharmacology | Fluoxetine - pharmacology | Promethazine - chemistry | Xenopus laevis | Propranolol - chemistry | Fluoxetine - chemistry | Verapamil - pharmacology | Haloperidol - chemistry | Verapamil - chemistry | Ether-A-Go-Go Potassium Channels - antagonists & inhibitors | Animals | Sotalol - pharmacology | Atenolol - chemistry | Hydrophobic and Hydrophilic Interactions | Terfenadine - chemistry | Chlorpheniramine - pharmacology | Imipramine - pharmacology | Potassium Channel Blockers - chemistry | Promethazine - pharmacology | Analysis | Models | Universities and colleges
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice
by Donahue, Timothy J and Hillhouse, Todd M and Webster, Kevin A and Young, Richard and De Oliveira, Eliseu O and Porter, Joseph H
Psychopharmacology, ISSN 0033-3158, 12/2017, Volume 234, Issue 23, pp. 3507 - 3520
Racemic (RS)-amisulpride (Solian®) is an atypical antipsychotic drug used to treat schizophrenia and dysthymia. Blockade of dopamine D2/D3 and/or serotonin... 
Drug discrimination | Neurosciences | Amisulpride | Schizophrenia | Isomers | Anxiolytics | Discriminative stimulus | Antipsychotics | Biomedicine | Antidepressants | C57BL/6 mice | Benzamides | Pharmacology/Toxicology | Psychiatry | CORTICAL MEMBRANES | PSYCHIATRY | HIGH-AFFINITY | MAJOR DEPRESSION | D-2 RECEPTORS | NEUROSCIENCES | RECEPTOR ANTAGONIST | LIMBIC SELECTIVITY | 5-HT7 RECEPTOR | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | RAT-BRAIN | DOPAMINE-RECEPTORS | Sulpiride - pharmacology | Conditioning, Operant - physiology | Male | Sulpiride - analogs & derivatives | Clozapine - pharmacology | Discrimination Learning - drug effects | Clozapine - chemistry | Conditioning, Operant - drug effects | Antidepressive Agents - chemistry | Anti-Anxiety Agents - chemistry | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Quetiapine Fumarate - pharmacology | Benzamides - chemistry | Quetiapine Fumarate - chemistry | Mice, Inbred C57BL | Chlorpromazine - chemistry | Risperidone - pharmacology | Anti-Anxiety Agents - pharmacology | Chlorpromazine - pharmacology | Risperidone - chemistry | Discrimination Learning - physiology | Animals | Antipsychotic Agents - chemistry | Mice | Antipsychotic Agents - pharmacology | Sulpiride - chemistry | Dosage and administration | Antipsychotic drugs | Comparative analysis | Drug interactions | Antianxiety agents | Stereoisomers | Drugs | Neuroleptics | Olanzapine | Operant conditioning | Mental disorders | Aripiprazole | Benzamide | Metoclopramide | Chlorpromazine | Sulpiride | Serotonin S7 receptors | Psychotropic drugs | Imipramine | Receptors | Bupropion | Mianserin | Risperidone | Dopamine D2 receptors | Drug dosages | Quetiapine | Raclopride | Dopamine | Serotonin | Dopamine D3 receptors | Chlordiazepoxide | Pharmacology | Clozapine | Derivatives | Properties (attributes) | Serotonin receptors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment
by Vicente, Maria Adrielle and Zangrossi, Helio
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 127 - 135
Facilitation of serotonin 2C- and 1A-receptor (5-HT2C-R and 5-HT1A-R) mediated neurotransmission in the basolateral nucleus of the amygdala (BLA) has been... 
Antidepressants and basolateral amygdala | Anxiety | Serotonin | 5-HT2C receptors | RATS | ELEVATED T-MAZE | ANXIETY-LIKE BEHAVIOR | FLUOXETINE | NEUROSCIENCES | OBSESSIVE-COMPULSIVE DISORDER | SEROTONIN REUPTAKE INHIBITORS | M-CPP | PHARMACOLOGY & PHARMACY | CHRONIC IMIPRAMINE | DORSAL PERIAQUEDUCTAL GRAY | PLUS-MAZE | Amygdala - drug effects | Rats, Wistar | Serotonin 5-HT1 Receptor Antagonists - pharmacology | Receptor, Serotonin, 5-HT2C - metabolism | Male | Serotonin 5-HT2 Receptor Agonists - pharmacology | Anxiety - drug therapy | Exploratory Behavior - physiology | Exploratory Behavior - drug effects | Receptor, Serotonin, 5-HT1A - metabolism | Fluoxetine - pharmacology | Panic - drug effects | Maze Learning - physiology | Anti-Anxiety Agents - pharmacology | Anxiety - physiopathology | Rats | Antidepressive Agents, Second-Generation - pharmacology | Avoidance Learning - physiology | Maze Learning - drug effects | Piperazines - pharmacology | Panic - physiology | Animals | Antidepressive Agents, Tricyclic - pharmacology | Avoidance Learning - drug effects | Pyridines - pharmacology | Imipramine - pharmacology | Pyrazines - pharmacology | Amygdala - physiology | Imipramine | Fluoxetine | Antianxiety agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway
by Guzmán-Gutiérrez, Silvia Laura and Bonilla-Jaime, Herlinda and Gómez-Cansino, Rocío and Reyes-Chilpa, Ricardo
Life Sciences, ISSN 0024-3205, 05/2015, Volume 128, pp. 24 - 29
Linalool and β-pinene are two volatile monoterpenes that possess antidepressant-like activity. These are components of many aromatic plants used in folk... 
Antidepressant | Monoterpenes | Aromatic compounds | β-Pinene | Linalool | MEDICINE, RESEARCH & EXPERIMENTAL | TRAMADOL | ESSENTIAL OILS | CHRONIC MILD STRESS | FORCED SWIMMING TEST | CLONIDINE | beta-Pinene | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | MICE | NORADRENALINE | BINDING | Serotonergic Neurons - physiology | Bridged Bicyclo Compounds - pharmacology | Serotonergic Neurons - drug effects | Male | Benzazepines - pharmacology | Serotonin Antagonists - pharmacology | Piperazines - pharmacology | Mice, Inbred ICR | Monoterpenes - pharmacology | Animals | Dopaminergic Neurons - drug effects | Antidepressive Agents - pharmacology | Pyridines - pharmacology | Adrenergic Neurons - drug effects | Imipramine - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice
by Rosa, Angelo Oscar and Lin, Jaime and Calixto, João Batista and Santos, Adair Roberto S and Rodrigues, Ana Lúcia S
Behavioural Brain Research, ISSN 0166-4328, 2003, Volume 144, Issue 1, pp. 87 - 93
This study investigated the involvement of NMDA receptors and the L-arginine-nitric oxide (NO) pathway in the antidepressant-like effects of zinc in the forced... 
Antidepressant | Nitric oxide | l-NNA | NMDA | Depression | l-arginine | Zinc | L-NNA | L-arginine | nitric oxide | TAIL SUSPENSION TEST | antidepressant | MAJOR DEPRESSION | FORCED SWIMMING TEST | NEUROSCIENCES | ASCORBATE | QUINOLINIC ACID | MODELS | REDOX | BEHAVIORAL SCIENCES | depression | LOWER SERUM ZINC | zinc | BRAIN | MODULATION | Free Radical Scavengers - pharmacology | Receptors, N-Methyl-D-Aspartate - metabolism | Motor Activity - drug effects | Male | Hindlimb Suspension - physiology | Dose-Response Relationship, Drug | Depression - drug therapy | Depression - metabolism | Drug Interactions | Time Factors | Zinc Compounds - pharmacology | Immobilization - physiology | Behavior, Animal - drug effects | Female | Antidepressive Agents - pharmacology | Swimming | Nitric Oxide Donors - pharmacology | Zinc Compounds - therapeutic use | Fluoxetine - pharmacology | Guanosine Monophosphate - pharmacology | Chlorides - pharmacology | Pain Measurement - drug effects | Excitatory Amino Acid Antagonists - pharmacology | Chlorides - therapeutic use | Antidepressive Agents - therapeutic use | Animals | Ascorbic Acid - pharmacology | Mice | Dizocilpine Maleate - pharmacology | Imipramine - pharmacology | Ketamine - pharmacology | Nitric Oxide - metabolism | S-Nitroso-N-Acetylpenicillamine - pharmacology | Arginine - metabolism | Drug Combinations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice
by Tomaz, V.S and Cordeiro, R.C and Costa, A.M.N and de Lucena, D.F and Nobre Júnior, H.V and de Sousa, F.C.F and Vasconcelos, S.M.M and Vale, M.L and Quevedo, J and Macêdo, D
Neuroscience, ISSN 0306-4522, 2014, Volume 268, pp. 236 - 246
Highlights • l -NAME, aminoguanidine and sildenafil prevent LPS-induced depressive-like behavior. • l -Arginine, a NO precursor, did not prevent LPS-induced... 
Neurology | nitric oxide | depressive-like behavior | neuroinflammation | BDNF | LPS | oxidative stress | Depressive-like behavior | Oxidative stress | Neuroinflammation | Nitric oxide | ACTIVATION | GUANOSINE-MONOPHOSPHATE PATHWAY | PREPULSE INHIBITION | NITROSATIVE STRESS | MAJOR DEPRESSION | KAPPA-B | NEUROSCIENCES | L-TRYPTOPHAN | ANIMAL-MODEL | ACOUSTIC STARTLE | PITUITARY-ADRENAL AXIS | Oxidative Stress - physiology | Nitric Oxide Synthase - antagonists & inhibitors | Depressive Disorder - drug therapy | Guanidines - pharmacology | Male | Sulfones - pharmacology | Lipopolysaccharides | Brain - metabolism | Sildenafil Citrate | Interleukin-1beta - metabolism | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Disease Models, Animal | NG-Nitroarginine Methyl Ester - pharmacology | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Behavior, Animal - physiology | Depressive Disorder - metabolism | Piperazines - pharmacology | Brain - drug effects | Animals | Cyclic GMP - metabolism | Signal Transduction - drug effects | Arginine - pharmacology | Depressive Disorder - prevention & control | Signal Transduction - physiology | Mice | Nitric Oxide Synthase - metabolism | Oxidative Stress - drug effects | Imipramine - pharmacology | Nitric Oxide - metabolism | Antidepressants | Mitogens | Depression, Mental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling
by Sutton, L.P and Rushlow, W.J
Neuroscience, ISSN 0306-4522, 2011, Volume 199, pp. 116 - 124
Abstract Glycogen synthase kinase-3 (GSK-3) has been implicated in the action of antipsychotics, mood stabilizers, and antidepressants. Given that only... 
Neurology | antipsychotic | mood stabilizer | GSK-3 | Akt | signal transduction | antidepressant | Antidepressant | Signal transduction | Antipsychotic | Mood stabilizer | MOUSE-BRAIN | DIFFERENTIAL EXPRESSION | PROTEIN | SCHIZOPHRENIC-PATIENTS | FRONTAL-CORTEX | BETA-CATENIN | NEUROSCIENCES | PREFRONTAL CORTEX | MESSENGER-RNA | IN-VIVO | LITHIUM | Fluoxetine - pharmacology | Immunoprecipitation | Antimanic Agents - pharmacology | Lithium - pharmacology | Rats | Male | Glycogen Synthase Kinase 3 - metabolism | Rats, Sprague-Dawley | Valproic Acid - pharmacology | beta Catenin - metabolism | Blotting, Western | Brain - drug effects | Clozapine - pharmacology | Animals | Signal Transduction - drug effects | Antidepressive Agents - pharmacology | Antipsychotic Agents - pharmacology | Imipramine - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Haloperidol - pharmacology | Drugs | Imipramine | Divalproex | Neurosciences | Synthesis | Fluoxetine | Glycogen | Analysis | Schizophrenia | Haloperidol | Clozapine | Valproic acid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights